These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1732066)

  • 1. Allylamine antifungal drugs.
    Ryder NS; Mieth H
    Curr Top Med Mycol; 1992; 4():158-88. PubMed ID: 1732066
    [No Abstract]   [Full Text] [Related]  

  • 2. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase.
    Petranyi G; Ryder NS; Stütz A
    Science; 1984 Jun; 224(4654):1239-41. PubMed ID: 6547247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action and biochemical selectivity of allylamine antimycotic agents.
    Ryder NS
    Ann N Y Acad Sci; 1988; 544():208-20. PubMed ID: 3063168
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology of the allylamines.
    Birnbaum JE
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 2):782-5. PubMed ID: 2229523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of terbinafine in cutaneous alternariosis.
    Altomare GF; Capella GL; Boneschi V; Viviani MA
    Br J Dermatol; 2000 Apr; 142(4):840-1. PubMed ID: 10792259
    [No Abstract]   [Full Text] [Related]  

  • 6. Terbinafine: mode of action and properties of the squalene epoxidase inhibition.
    Ryder NS
    Br J Dermatol; 1992 Feb; 126 Suppl 39():2-7. PubMed ID: 1543672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal agents: an overview. Part II.
    Gupta AK; Sauder DN; Shear NH
    J Am Acad Dermatol; 1994 Jun; 30(6):911-33; quiz 934-6. PubMed ID: 7619094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naftifine: a topical allylamine antifungal agent.
    Mühlbacher JM
    Clin Dermatol; 1991; 9(4):479-85. PubMed ID: 1822408
    [No Abstract]   [Full Text] [Related]  

  • 9. Squalene epoxidase as a target for the allylamines.
    Ryder NS
    Biochem Soc Trans; 1991 Aug; 19(3):774-7. PubMed ID: 1783214
    [No Abstract]   [Full Text] [Related]  

  • 10. [Naftifin--laboratory and clinical experience with a new antimycotic from the allylamine group].
    Otcenásek M; Péc J; Moravcík P
    Cas Lek Cesk; 1993 Jun; 132(13):406-9. PubMed ID: 8370053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ergosterol biosynthesis inhibition by the thiocarbamate antifungal agents tolnaftate and tolciclate.
    Ryder NS; Frank I; Dupont MC
    Antimicrob Agents Chemother; 1986 May; 29(5):858-60. PubMed ID: 3524433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimycotic susceptibility testing of mould-fungi with allylamines by disk diffusion.
    Venugopal PV; Venugopal TV
    Indian J Med Sci; 1995 May; 49(5):109-13. PubMed ID: 8772831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naftifine: a review.
    Gupta AK; Ryder JE; Cooper EA
    J Cutan Med Surg; 2008; 12(2):51-8. PubMed ID: 18346400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents.
    Favre B; Ryder NS
    Antimicrob Agents Chemother; 1996 Feb; 40(2):443-7. PubMed ID: 8834895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of antifungal agents on germ tube formation in Candida albicans.
    Schaude M; Ackerbauer H; Mieth H
    Mykosen; 1987 Jun; 30(6):281-7. PubMed ID: 3306370
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms of action of systemic antifungal agents.
    Elewski BE
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):S28-S34. PubMed ID: 8496409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro studies with SF 86-327, a new orally active allylamine derivative.
    Shadomy S; Espinel-Ingroff A; Gebhart RJ
    Sabouraudia; 1985 Apr; 23(2):125-32. PubMed ID: 2990057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses.
    Monk JP; Brogden RN
    Drugs; 1991 Oct; 42(4):659-72. PubMed ID: 1723367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terbinafine: an oral and topical antifungal agent.
    Shear NH; Villars VV; Marsolais C
    Clin Dermatol; 1991; 9(4):487-95. PubMed ID: 1840406
    [No Abstract]   [Full Text] [Related]  

  • 20. The mode of antifungal action of tolnaftate.
    Barrett-Bee KJ; Lane AC; Turner RW
    J Med Vet Mycol; 1986 Apr; 24(2):155-60. PubMed ID: 3522841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.